Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Yosuke Nonaka"'
Autor:
Yosuke Nonaka, Yuki K. Wakabayashi, Goro Shibata, Shoya Sakamoto, Keisuke Ikeda, Zhendong Chi, Yuxuan Wan, Masahiro Suzuki, Tsuneharu Koide, Masaaki Tanaka, Ryosho Nakane, Atsushi Fujimori
Publikováno v:
AIP Advances, Vol 11, Iss 8, Pp 085317-085317-5 (2021)
Spinel-type CoFe2O4 is a ferrimagnetic insulator with the Néel temperature exceeding 790 K, and it shows strong cubic magnetocrystalline anisotropy (MCA) in bulk materials. However, when a CoFe2O4 film is grown on other materials, its magnetic prope
Externí odkaz:
https://doaj.org/article/88179e8daed7420ba8d38bddd0f106d9
Autor:
Yusaku Matsuda, Yosuke Nonaka, Satoshi Futakawa, Hirotaka Imai, Kazumasa Akita, Toshiaki Nishihata, Masatoshi Fujiwara, Yusuf Ali, Robert B. Bhisitkul, Yoshikazu Nakamura
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 17, Iss , Pp 819-828 (2019)
Currently approved therapies for age-related macular degeneration (AMD) are inhibitors against vascular endothelial growth factor (VEGF), which is a major contributor to the pathogenesis of neovascular AMD (nAMD). Intravitreal injections of anti-VEGF
Externí odkaz:
https://doaj.org/article/80978e83ce7e4da59a94b6e8f58f10e5
Autor:
Denan Jin, Shinji Takai, Yosuke Nonaka, Satoko Yamazaki, Masatoshi Fujiwara, Yoshikazu Nakamura
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 14, Iss , Pp 41-51 (2019)
We have reported that mast cell chymase, an angiotensin II-generating enzyme, is important in cardiovascular tissues. Recently, we developed a new chymase-specific inhibitory RNA aptamer, HA28, and we evaluated the effects of HA28 on cardiac function
Externí odkaz:
https://doaj.org/article/df37865be8184ae1bbf629995fa6b705
Autor:
Isao Kii, Yuto Sumida, Toshiyasu Goto, Rie Sonamoto, Yukiko Okuno, Suguru Yoshida, Tomoe Kato-Sumida, Yuka Koike, Minako Abe, Yosuke Nonaka, Teikichi Ikura, Nobutoshi Ito, Hiroshi Shibuya, Takamitsu Hosoya, Masatoshi Hagiwara
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-14 (2016)
Kinase inhibitors are important drugs and usually target the ATP binding pocket of kinases. Here, Kii et al.report a completely new type of kinase inhibitor that specifically targets the protein folding intermediate state, but not the mature form, of
Externí odkaz:
https://doaj.org/article/cc58fcf33b4145468837fef116260032
Autor:
Takeshi Hiramoto, Yosuke Nonaka, Kazuko Inoue, Takefumi Yamamoto, Mariko Omatsu-Kanbe, Hiroshi Matsuura, Keigo Gohda, Norihisa Fujita
Publikováno v:
Journal of Pharmacological Sciences, Vol 95, Iss 1, Pp 81-93 (2004)
G protein-coupled receptors (GPCRs) are distributed widely throughout the human body, and nearly 50% of current medicines act on a GPCR. GPCRs are considered to consist of seven transmembrane α-helices that form an α-helical bundle in which agonist
Externí odkaz:
https://doaj.org/article/8528c68d9d494f85b4c708ca72a782f5
Autor:
Yosuke Nonaka, Yuki K. Wakabayashi, Goro Shibata, Shoya Sakamoto, Keisuke Ikeda, Zhendong Chi, Yuxuan Wan, Masahiro Suzuki, Arata Tanaka, Masaaki Tanaka, Atsushi Fujimori
Publikováno v:
Physical Review Materials. 7
Publikováno v:
Tetsu-to-Hagane. 108:199-210
Autor:
Masahiro Suzuki, Yosuke Nonaka, Arata Tanaka, Tsuneharu Koide, Sang-Wook Cheong, Atsushi Fujimori, Goro Shibata, Keisuke Ikeda, Jaewook Kim, Choongjae Won, Yuxuan Wan
Publikováno v:
The Journal of Physical Chemistry C. 125:12929-12936
Titanium disulfide TiS$_2$, which is a member of the layered transition-metal dichalcogenides with the 1T-CdI$_2$-type crystal structure, is known to exhibit a wide variety of magnetism through intercalating various kinds of transition-metal atoms of
Autor:
Hakuto Suzuki, Guoqiang Zhao, Jun Okamoto, Shoya Sakamoto, Zhi-Yin Chen, Yosuke Nonaka, Goro Shibata, Kan Zhao, Bijuan Chen, Wen-Bin Wu, Fan-Hsiu Chang, Hong-Ji Lin, Chien-Te Chen, Arata Tanaka, Masaki Kobayashi, Bo Gu, Sadamichi Maekawa, Yasutomo J. Uemura, Changqing Jin, Di-Jing Huang, Atsushi Fujimori
Publikováno v:
Journal of the Physical Society of Japan. 91
Autor:
Yoshikazu Nakamura, Toshiaki Nishihata, Satoshi Futakawa, Yusaku Matsuda, Hirotaka Imai, Masatoshi Fujiwara, Yusuf Ali, Kazumasa Akita, Robert B. Bhisitkul, Yosuke Nonaka
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 17, Iss, Pp 819-828 (2019)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
Currently approved therapies for age-related macular degeneration (AMD) are inhibitors against vascular endothelial growth factor (VEGF), which is a major contributor to the pathogenesis of neovascular AMD (nAMD). Intravitreal injections of anti-VEGF